Kava: Calm, Sleep and Liver Risk
Kava lowered anxiety scores in several short trials, then failed to beat placebo in a 16-week trial of 171 people. It also carries a rare but documented risk of serious liver injury.

Still logging injections in your Notes app?
A notes thread can't show a missed day at a glance, because it's a list, not a calendar. A printed log can. Your compounds and dates filled in: injection log, weekly schedule, dated calendar. Free to build and preview; $5/month to unlock printing.
How Does Kava Work in the Brain?
Kavain, the main kavalactone, boosted the response of every human GABA-A receptor type tested in frog egg cells. Flumazenil, which blocks the benzodiazepine site, did not stop the effect, so kavain does not work through the benzodiazepine binding site (kavain GABA-A receptor study, PMID 27332705).
In 37 adults with generalized anxiety disorder, 8 weeks of kava at 120 mg kavalactones twice daily lowered GABA in the dorsal anterior cingulate cortex compared with placebo (p = 0.049). The drop was not linked to changes in anxiety scores (kava dACC GABA neuroimaging study, PMID 37960239).
A single 180 mg kavalactone dose had no negative effect on cognition in 22 anxious adults, while 30 mg of oxazepam reduced alertness. The same kava dose also failed to reduce anxiety acutely in these first-time users (acute kava and oxazepam study, PMID 22311378).
In rats, a kava (Piper methysticum) extract raised peak blood levels of the sedative midazolam 4-fold by blocking cytochrome P450 3A (CYP3A) metabolism in the gut. This was an animal study (valerian and kava CYP3A study, PMID 39013429).
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- A Cochrane review of 11 trials with 645 participants found that kava extract lowered Hamilton Anxiety scores by 5.0 points more than placebo across 6 pooled trials, with mild, transient and infrequent adverse events over 1 to 24 weeks (PMID 12535473).
- In a 6-week trial in generalized anxiety disorder, kava reduced anxiety more than placebo (Cohen d = 0.62), and 26% of the kava group were in remission vs 6% on placebo (PMID 23635869). Kava did not differ from placebo on liver function tests, withdrawal or addiction in that trial (PMID 23348842).
- In the 16-week trial of 171 people with generalized anxiety disorder, kava did no better than placebo: 17.4% remitted on kava vs 23.8% on placebo (PMID 31813230).
- In 61 patients with sleep problems tied to anxiety, 200 mg a day of the extract WS 1490 for 4 weeks improved sleep quality and how rested people felt after sleep compared with placebo (PMID 14706720).
- A single medicinal dose of 180 mg kavalactones did not impair cognition (PMID 22311378) or simulated driving, while 30 mg of oxazepam slowed braking reaction time (PMID 23259514).
- By 2002, 11 kava users in Germany, Switzerland and the United States had liver failure and underwent liver transplantation, and the FDA issued a consumer advisory on March 25, 2002 (PMID 12500906).
- Liver injury has also followed traditional water-based kava drinks in New Caledonia, Australia, the USA and Germany, so the solvent alone does not explain it (PMID 21801196).
- Whether kava helps diagnosed generalized anxiety disorder. The two GAD trials disagree (PMID 23635869, PMID 31813230), and a network meta-analysis found kava effective for anxiety overall but possibly ineffective in GAD (PMID 35378276).
- What causes the liver injury. Reviews point to poor quality raw material (PMID 21801196), which may have been contaminated after harvest by mould toxins such as aflatoxins, a question that still needs study (PMID 21377431). Pipermethystine was not detectable in Western extracts, and flavokavain B was present at levels too low to injure the liver in animal experiments (PMID 21377431).
- Who is most at risk. In most of 14 patients with suspected kava liver injury, the risk factors included overdose, prolonged treatment, and taking kava with synthetic drugs or other supplements (PMID 20720265).
- What longer use does. Over 16 weeks, liver function test abnormalities were more frequent on kava, although no participant met criteria for herb-induced liver injury, and poorer memory and tremor were reported more often on kava (PMID 31813230).
- What heavy traditional use does over years. In an Arnhem Land community study of 101 adults, kava users had more skin changes (dermopathy), higher GGT and alkaline phosphatase, and lower lymphocyte counts, with no difference on neurocognitive tests (PMID 12895162).
- Whether you can drive after a long kava session. After about 6 hours and 3.6 L of kava, drinkers showed impaired temporal order judgement (PMID 35151837), and four Iowa drivers who reported kava use showed poor driving and signs of intoxication (PMID 31305953).
Frequently Asked Questions
Is kava bad for your liver?
It can be, rarely. A 2002 CDC report counted 11 kava users in Germany, Switzerland and the United States who had liver failure and needed a transplant (kava hepatic toxicity report, PMID 12500906). A later clinical review of 14 cases named overdose, prolonged treatment and taking kava with other drugs or supplements as risk factors, and pointed to poor raw material quality (kava hepatotoxicity clinical review, PMID 20720265). In the 16-week trial, liver test abnormalities were more frequent on kava, but no participant met criteria for herb-induced liver injury (16-week kava GAD trial, PMID 31813230).
Does kava work for anxiety?
In short trials, usually. The Cochrane review of 11 trials found Hamilton Anxiety scores fell 5.0 points more on kava than on placebo (Cochrane kava extract review, PMID 12535473). In a 16-week trial in 171 people with generalized anxiety disorder, kava did not beat placebo (16-week kava GAD trial, PMID 31813230).
Does kava help you sleep?
One trial says yes for sleep problems that come with anxiety. In 61 patients, 200 mg a day of the kava extract WS 1490 for 4 weeks improved sleep quality and how rested people felt after sleep compared with placebo (WS 1490 sleep disturbance trial, PMID 14706720).
Does kava affect focus, memory or driving?
A single medicinal dose did not measurably impair them. A 180 mg kavalactone dose had no negative effect on cognition, while oxazepam reduced alertness (acute kava and oxazepam study, PMID 22311378), and the same dose did not impair simulated driving (medicinal kava dose driving study, PMID 23259514). Daily use is different: over 16 weeks at 120 mg kavalactones twice a day, poorer memory was reported more often on kava than on placebo, 36 vs 23 (16-week kava GAD trial, PMID 31813230). After about 6 hours and 3.6 L at a traditional session, temporal order judgement was impaired (traditional kava cognition and driver fitness study, PMID 35151837).
What is noble kava, and is it safer?
Noble kava means cultivars defined in the Vanuatu Kava Act of December 2002 and described as well tolerated. Liver researchers proposed using a noble cultivar such as Borogu, at least 5 years old at harvest, with peeled rhizomes and roots, water extraction and 250 mg kavalactones a day or less (six-point kava standardization plan, PMID 21112196). That plan is a proposal, and liver injury has also followed traditional water-based kava drinks (Pacific kava paradox review, PMID 21801196).
Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links support HighPeptides at no extra cost.
Related HighPeptides Research
Peer-Reviewed References
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →Educational purposes only. Not medical advice.
Kava is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it if you have liver disease, take prescription medicines or sedatives, drink alcohol regularly, or are pregnant.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.